Access cutting-edge prurigo nodularis treatment through this clinical trial at a research site in Palo Alto. Study-provided care at no cost to qualified participants.
Access prurigo nodularis specialists in Palo Alto at no cost
This study follows strict safety protocols and ethical guidelines
All study-related prurigo nodularis treatment provided free
This is a Phase 3, multicenter, open-label, pharmacokinetics (PK)/safety study. The study consists of 3 periods: * Screening period: 2 to 4 weeks. * Treatment period: 24 weeks. * Post-intervention follow-up period: 16 weeks. The study duration will be approximately 42 to 44 weeks for each participant (including screening, treatment, and follow-up periods). The total number of planned study visits for each participant will be 6.
Sponsor: Sanofi
Check if you qualify for this prurigo nodularis clinical trial in Palo Alto, CA
If you're searching for prurigo nodularis treatment options in Palo Alto, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Palo Alto research site is actively enrolling participants for this clinical trial. You'll receive care from experienced prurigo nodularis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.